Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | PD184352 | 0.1 | uM | 3 | SCF | 31.0 | 67 | ||||
RA2159 | Lestaurtinib | 0.3 | uM | 3 | SCF | 30.0 | 61 | ||||
RA2159 | Ruxolitinib | 0.3 | uM | 3 | SCF | 39.0 | 73 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 3 | SCF | 34.0 | 65 | ||||
RA2159 | IKK16 | 2.0 | uM | 3 | SCF | 34.0 | 51 | ||||
RA2159 | JNK-IN-8 | 3.0 | uM | 3 | SCF | 34.0 | 84 | ||||
N2586 | 3 | SCF | 65.5 | 62 | |||||||
N2586 | PD184352 | 0.1 | uM | 3 | SCF | 72.0 | 65 | ||||
N2586 | Lestaurtinib | 0.3 | uM | 3 | SCF | 57.0 | 79 | ||||
N2586 | Ruxolitinib | 0.3 | uM | 3 | SCF | 96.0 | 73 | ||||
N2586 | Tofacitinib | 0.3 | uM | 3 | SCF | 70.0 | 75 | ||||
N2586 | IKK16 | 2.0 | uM | 3 | SCF | 53.0 | 60 | ||||
N2586 | JNK-IN-8 | 3.0 | uM | 3 | SCF | 50.5 | 58 | ||||
RA2159 | IL-17A | 100 | ng/mL | 3 | SCF | 40.0 | 93 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 3 | SCF | 34.0 | 78 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | SCF | 36.5 | 68 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | SCF | 34.0 | 61 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | SCF | 36.0 | 69 | |
RA2159 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 3 | SCF | 34.0 | 76 | |
N2586 | IL-17A | 100 | ng/mL | 3 | SCF | 70.5 | 76 | ||||
N2586 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 3 | SCF | 78.0 | 87 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | SCF | 60.5 | 66 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | SCF | 122.0 | 69 | |
N2586 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 3 | SCF | 51.0 | 72 | |
N2586 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 3 | SCF | 50.0 | 78 |